Eran Matz

676 total citations
52 papers, 384 citations indexed

About

Eran Matz is a scholar working on Genetics, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Eran Matz has authored 52 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 28 papers in Epidemiology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Eran Matz's work include Inflammatory Bowel Disease (36 papers), Microscopic Colitis (25 papers) and Pregnancy and Medication Impact (7 papers). Eran Matz is often cited by papers focused on Inflammatory Bowel Disease (36 papers), Microscopic Colitis (25 papers) and Pregnancy and Medication Impact (7 papers). Eran Matz collaborates with scholars based in Israel, United States and Canada. Eran Matz's co-authors include Iris Dotan, Dan Turner, Shira Greenfeld, Revital Kariv, Yiska Loewenberg Weisband, Ohad Atia, Gili Focht, Daniel Nevo, Amir Ben‐Tov and Yehuda Chowers and has published in prestigious journals such as Gastroenterology, PLoS ONE and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Eran Matz

46 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eran Matz Israel	12	215	186	92	57	48	52	384
Hang Hock Shim Singapore	11	180 0.8×	171 0.9×	89 1.0×	32 0.6×	49 1.0×	23	301
Sadie M. Marden United Kingdom	5	344 1.6×	278 1.5×	97 1.1×	13 0.2×	77 1.6×	6	514
Sasha Taleban United States	11	211 1.0×	184 1.0×	116 1.3×	38 0.7×	32 0.7×	33	388
Lucy Artinian United States	7	225 1.0×	645 3.5×	168 1.8×	45 0.8×	21 0.4×	7	894
Jeffrey Berinstein United States	12	321 1.5×	284 1.5×	154 1.7×	140 2.5×	64 1.3×	60	611
Dhruvan Patel United States	12	192 0.9×	177 1.0×	79 0.9×	94 1.6×	56 1.2×	38	461
Ondřej Hradský Czechia	14	303 1.4×	212 1.1×	249 2.7×	52 0.9×	210 4.4×	55	653
Nienke Ipenburg Netherlands	5	280 1.3×	204 1.1×	99 1.1×	15 0.3×	50 1.0×	7	363
Mia Cilissen Netherlands	3	400 1.9×	275 1.5×	159 1.7×	18 0.3×	29 0.6×	7	531
Manar Matar Israel	9	281 1.3×	216 1.2×	105 1.1×	14 0.2×	106 2.2×	35	392

Countries citing papers authored by Eran Matz

Since Specialization

Citations

This map shows the geographic impact of Eran Matz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eran Matz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eran Matz more than expected).

Fields of papers citing papers by Eran Matz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eran Matz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eran Matz. The network helps show where Eran Matz may publish in the future.

Co-authorship network of co-authors of Eran Matz

This figure shows the co-authorship network connecting the top 25 collaborators of Eran Matz. A scholar is included among the top collaborators of Eran Matz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eran Matz. Eran Matz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Atia, Ohad, Amir Ben‐Tov, Mehdi Osooli, et al.. (2024). The Epidemiology of Inflammatory Bowel Diseases During the COVID-19 Pandemic: Comparison of Two Nationwide Cohorts. Journal of Crohn s and Colitis. 18(8). 1241–1249. 5 indexed citations

Weisband, Yiska Loewenberg, et al.. (2024). P1116 Risk of fractures in children and adults with inflammatory bowel disease: A report from the epi-IIRN. Journal of Crohn s and Colitis. 18(Supplement_1). i1989–i1990. 1 indexed citations

Focht, Gili, Shira Greenfeld, Revital Kariv, et al.. (2024). Enteral nutrition compared with corticosteroids in children with Crohn's disease: A long‐term nationwide study from the epi‐IIRN. Alimentary Pharmacology & Therapeutics. 60(2). 224–232. 2 indexed citations

Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2024). Predictors of Complicated Disease Course in Adults and Children With Crohn’s Disease: A Nationwide Study from the epi-IIRN. Inflammatory Bowel Diseases. 30(12). 2370–2379. 3 indexed citations

Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2024). Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRN. Inflammatory Bowel Diseases. 31(3). 655–664. 3 indexed citations

Yerushalmy‐Feler, Anat, Yiska Loewenberg Weisband, Shira Greenfeld, et al.. (2024). Peripheral Blood Eosinophilia at Diagnosis of Inflammatory Bowel Disease Is Associated With Severe Disease Course: A Nationwide Study From the epi-IIRN Cohort. Journal of Crohn s and Colitis. 19(2). 1 indexed citations

Focht, Gili, Shira Greenfeld, Amir Ben‐Tov, et al.. (2024). Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort. Gastroenterology. 166(5). 815–825.e22. 5 indexed citations

Focht, Gili, Ohad Atia, Shira Greenfeld, et al.. (2023). OP12 Does early initiation of biologics change the natural history of IBD? a nationwide study from the epi-IIRN. Journal of Crohn s and Colitis. 17(Supplement_1). i17–i18. 2 indexed citations

Ein‐Mor, Eliana, Ronit Calderon‐Margalit, Adam J. Rose, et al.. (2023). Nationwide Evaluation of Quality of Care Indicators for Individuals with Severe Mental Illness and Diabetes Mellitus, Following Israel’s Mental Health Reform. Community Mental Health Journal. 60(2). 354–365.

10.

Atia, Ohad, Gili Focht, Shira Greenfeld, et al.. (2023). Durability of the First Biologic in Patients with Crohn’s Disease: A Nationwide Study from the epi-IIRN. Journal of Crohn s and Colitis. 18(1). 38–46. 6 indexed citations

11.

Ledder, Oren, Esther Orlanski‐Meyer, Yiska Loewenberg Weisband, et al.. (2023). Residence in Peripheral Regions and Low Socioeconomic Status Are Associated With Worse Outcomes of Inflammatory Bowel Diseases: A Nationwide Study From the epi-IIRN. Inflammatory Bowel Diseases. 30(1). 1–8. 3 indexed citations

12.

Atia, Ohad, Idan Goren, Shira Greenfeld, et al.. (2023). 5‐aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease—A nationwide cohort study. Alimentary Pharmacology & Therapeutics. 57(9). 1004–1013. 12 indexed citations

13.

Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2023). Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN. Inflammatory Bowel Diseases. 30(2). 213–221. 6 indexed citations

14.

Gorelik, Yuri, Yiska Loewenberg Weisband, Shira Greenfeld, et al.. (2023). Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a Report from the epi-IIRN. Journal of Crohn s and Colitis. 17(9). 1410–1417. 2 indexed citations

15.

Bar-Hillel, Aharon, Raffi Lev‐Tzion, Shira Greenfeld, et al.. (2023). Medical concept embedding of real-valued electronic health records with application to inflammatory bowel disease. Artificial Intelligence in Medicine. 145. 102684–102684. 1 indexed citations

16.

Atia, Ohad, Idan Goren, Yiska Loewenberg Weisband, et al.. (2023). P467 5-ASA is not superior to no-maintenance in patients with newly diagnosed Crohn’s disease - a nationwide cohort from the epi-IIRN. Journal of Crohn s and Colitis. 17(Supplement_1). i596–i596. 1 indexed citations

17.

Dolev, Amit, Shira Greenfeld, Revital Kariv, et al.. (2023). P269 Predicting IBD years before diagnosis using routine blood tests. Journal of Crohn s and Colitis. 17(Supplement_1). i417–i418.

18.

Atia, Ohad, Eric I. Benchimol, Shira Greenfeld, et al.. (2022). Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN Study. Clinical Gastroenterology and Hepatology. 21(10). 2639–2648.e6. 12 indexed citations

19.

Atia, Ohad, Esther Orlanski‐Meyer, Shira Greenfeld, et al.. (2021). Improved Outcomes of Paediatric and Adult Crohn’s Disease and Association With Emerging Use of Biologics–A Nationwide Study From the Epi-IIRN. Journal of Crohn s and Colitis. 16(5). 778–785. 19 indexed citations

20.

Atia, Ohad, Esther Orlanski‐Meyer, Shira Greenfeld, et al.. (2021). Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN. Journal of Crohn s and Colitis. 16(5). 796–803. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact